HER2 Support Group Forums - View Single Post - Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 posit

News · 04-21-2011, 06:20 AM

Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.

More...

04-21-2011, 06:20 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,154	Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 posit Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors. More...